01 十一月 2013

Anteis sold to Merz Pharma

Merz Pharma, the Germany based pharmaceutical company, acquires Anteis S.A., the Switzerland based company that develops, manufactures, and distributes injectable medical devices based on bio-polymer transformation, from Matignon Investissement & Gestion, BB Biotech Ventures G.P., and Signet Healthcare Partners, for an undisclosed consideration. Anteis S.A. has 150 employees. Matignon, BB Biotech and Signet are represented by VISCHER (Dr. Matthias Staehelin, Partner, Marius Meier, Associate).

分享文章至:

包含的服务:

与我们的作者取得联系,受益于他们的专业知识:

partner-Matthias-0

Matthias Staehelin

matthias.staehelin@vischer.com

+41 58 211 33 53

我们的
新闻通讯

Anteis sold to Merz Pharma